It should be the case that wherever you are in our region, you have equal access to the best treatments available. We are working hard to make this a reality. Our commitment to people impacted by cancer continues by funding rehabilitation programmes that focus on reducing the risk of cancer returning.
Cancer type: Bowel
More than 1300 people die from bowel cancer in Yorkshire every year. We are committed to reducing this figure by implementing a gold standard of bowel cancer care, which is provided regardless of where treatment is received in our region.Learn more
Cancer type: General
Radiotherapy treatment for lung cancer can sometimes damage the heart. Thanks to our funding, researchers at Leeds Teaching Hospitals NHS Trust have joined forces with The University of Manchester and a specialist cancer centre (The Christie NHS Foundation Trust in Manchester) to try to stop this.
They will investigate which parts of the heart are most susceptible to damage so these areas can be avoided or protected. This could improve the chances of patients surviving a year or more by around 10%. The findings could be applied in other cancers where radiotherapy is commonly used such as breast cancer.
Cancer type: Lung
75% of lung cancer patients have other lung diseases that mean they are at a higher risk of complications following curative surgery. Thanks to our funding, the University of Sheffield and Sheffield Teaching Hospitals are focusing on using cutting-edge lung images to help work out the best treatment option (surgery or radiotherapy) for patients with lung cancer. The study will use the city’s world-leading magnetic resonance imaging (MRI) centre to produce revolutionary pictures of cancer patients’ lungs before they begin treatment. If successful, this work could lead to improved treatment decision-making across Yorkshire and the UK - getting this choice right will improve survival and quality of life for those undergoing treatment.